Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit
Weekly DigestUnited States Court of Appeals
for the Federal Circuit
September 17, 2026
Appeal No. 2025-1427 ENANTA PHARMACEUTICALS, INC.,
Plaintiff-Appellant
v.
Defendant-Appellee Decided: June 23, 2026 Precedential Opinion
The following changes have been made:
On page 2, line 5, “all” has been deleted On page 2, footnote 1, “all claims” has been replaced with “the asserted claims (1, 2, 5, 7–10)”
Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.
Analysis is coming soon.
A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., No. 25-1427 (Fed. Cir. June 23, 2026).
No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.
Source: govinfo.gov USCOURTS collection · retrieved September 18, 2026 · Report an error